ROIV — Roivant Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Roivant Sciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2,183	2,055	2,060	1,677	6,536
Net Total Accounts Receivable
Net Total Receivables	15.3	13.8	—	32.7	82.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,219	2,187	2,147	1,799	6,732
Net Property, Plant And Equipment	73.9	77	86.9	92.3	66
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,477	2,590	2,585	2,390	7,222
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	92.1	219	184	272	267
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	445	792	928	1,232	1,254
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2,032	1,798	1,657	1,158	5,969
Total Liabilities & Shareholders' Equity	2,477	2,590	2,585	2,390	7,222
Total Common Shares Outstanding